Healthcare & Life Sciences
Oxford BioTherapeutics
United Kingdomwww.oxfordbiotherapeutics.com
Oxford BioTherapeutics is a Healthcare & Life Sciences startup based in the United Kingdom, most recent round Series B, 3 tracked investors.
activeseries-b
series-b
Stage
2015
Founded
3
Investors
About Oxford BioTherapeutics
Oxford BioTherapeutics is a company founded in 2015 headquartered in the United Kingdom. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 3 investors associated with the company.
Oxford BioTherapeutics is a clinical-stage oncology company developing first-in-class antibody-based therapies, including Antibody-Drug Conjugates (ADCs) and T-cell engagers (TCEs), to improve patient outcomes in cancer treatment.
Explore Oxford BioTherapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.
Other Startups in United Kingdom
Oxford Biomedicaseries-c-plusOxford BioelectronicsOxford BiodynamicsseedOxford Aviation AcademyOxehealthseries-c-plusOxecoseries-c-plusOxford Brain Diagnosticsseries-aOxford Cancer Biomarkersseries-aOxford Cannabinoid TechnologiesseedOxford Drug DesignseedOxford Dynamicsseries-aOxford Flowseries-c-plus